Publicación: On the normative foundations of pharmaceutical regulation
Cargando...
Fecha
2017-06-08
Autores
Editor/a
Director/a
Tutor/a
Coordinador/a
Prologuista
Revisor/a
Ilustrador/a
Derechos de acceso
Atribución-NoComercial-SinDerivadas 4.0 Internacional
Título de la revista
ISSN de la revista
Título del volumen
Editor
['Barbara Osimani', 'Adam LaCaze']
Resumen
I argue that behind the 1962 Food and Drug Administration Act we find a combination of two normative principles: a liberal argument for the protection of pharmaceutical markets (in terms of quality control) and a paternalist argument for the protection of pharmaceutical consumers (in terms of drug safety and efficacy). These normative intuitions go hand in hand with the choice of regulatory testing standards: depending on the values the regulator wants to protect, she will avail herself of different testing methods. I explore two potential justifications for regulatory paternalism, in terms of risk aversion and impartiality. I defend our current regulatory arrangement against socialist and libertarian critiques.
Descripción
Categorías UNESCO
Palabras clave
FDA, Regulation, clinical trials
Citación
Centro
Facultades y escuelas::Facultad de Filosofía
Departamento
Lógica, Historia y Filosofía de la Ciencia